Last reviewed · How we verify
NCT03539497
Prognostic Value of Plasma Mitochondrial DNA and Cytochrome C After Cardiac Arrest
trial testing Biomarker in Cardiac Arrest in 87 participants. Status unknown.
23 August 2023
Quick facts
| Lead sponsor | University Medical Centre Ljubljana |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 87 |
| Start date | 8 January 2019 |
| Primary completion | 23 August 2023 |
| Estimated completion | 30 March 2024 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- Biomarker — full drug profile →
Conditions studied
- Cardiac Arrest — all drugs for Cardiac Arrest →
Sponsor
University Medical Centre Ljubljana
Who can join
14 and older, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to determine prognostic value of plasma mitochondrial DNA and cytochrome C after cardiac arrest. The study will be conducted in three parts: 1. Determine plasma concentrations of mitochondrial DNA and cytochrome C in healthy population. 2. Determine release profile of mitochondrial DNA and cytochrome C to plasma after cardiac arrest. 3. Determine plasma prognostic value of mitochondrial DNA and cytochrome C after cardiac arrest and compare it with established prognostic methods.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Markers of Mitochondrial Injury and Neurological Outcomes of Comatose Patients after Cardiac Arrest.
Živanović I, Miš K, Pirkmajer S, Marić I, et al · · 2024 · PMID 39202565 · DOI 10.3390/medicina60081286
Verify or expand the search:
- PubMed search for NCT03539497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biomarker
Trials testing the same drug.
- NCT05199025 — Biomarkers in Perioperative Management · recruiting
- NCT03715569 — CNS Infections Effect on the Inner Ear · unknown
- NCT03295825 — Heparin Binding Protein in Early Sepsis Diagnosis · NA · completed
Other recruiting trials for Cardiac Arrest
Currently open trials in the same condition.
- NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
- NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
- NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
- NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
- NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting
Other University Medical Centre Ljubljana trials
Trials by the same sponsor.
- NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
- NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
- NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
- NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
- NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03539497 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
- Last refreshed: 6 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03539497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing